Literature DB >> 24990229

Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia.

Tiina Talaslahti1, Hanna-Mari Alanen, Helinä Hakko, Matti Isohanni, Unto Häkkinen, Esa Leinonen.   

Abstract

OBJECTIVE: In this register-based study of schizophrenia patients aged 65 years or above, mortality and causes of death diagnosed at age of 60+ (very-late-onset schizophrenia-like psychosis, VLOSLP) were studied in comparison with sex- and age-matched general Finnish population. Standardized Mortality Ratios (SMRs) of VLOSLP patients were also compared with those of earlier onset (below 60 years) schizophrenia patients, and hazard of death was calculated between these patient groups.
METHODS: The data was obtained from Finnish nationwide registers and consisted of 918 VLOSLP patients and 6142 earlier onset patients who were at least 65 years on 1 January 1999. The register-based follow-up for mortality covered 10 years between 1999 and 2008.
RESULTS: Overall SMR was 5.02 (4.61-5.46) in the group of VLOSLP patients and 2.93 (2.83-3.03) in the group of earlier onset patients. In men, SMRs were 8.31 (7.14-9.62; n = 179) and 2.91 (2.75-3.07, n = 1316) and in women 4.21 (3.78-4.66; n = 364) and 2.94 (2.82-3.07, n = 2055). In the VLOSLP group, SMRs were higher in most causes-of-death categories such as accidents, respiratory diseases, dementias, neoplasms and circulatory diseases. However, in direct comparison adjusted for several variables, the difference between these groups was minimal (Hazard Ratio, HR, 1.16 95%CI 1.05-1.27, p = 0.003).
CONCLUSION: Patients with VLOSLP, especially men, are at even higher risk of death than schizophrenia patients with earlier onset. Physical comorbidities and accidents in the VLOSLP group mostly explained this result. Targeted clinical interventions with effective collaboration between psychiatry and primary and specialist-level somatic care are crucial to reduce their excess mortality
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  age at onset; aged; cause of death; mortality; schizophrenia

Mesh:

Year:  2014        PMID: 24990229     DOI: 10.1002/gps.4159

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  5 in total

1.  Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study.

Authors:  Margaux Chene; Marina Sánchez-Rico; Carlos Blanco; Rachel Pascal De Raykeer; Cécile Hanon; Pierre Vandel; Frédéric Limosin; Nicolas Hoertel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-20       Impact factor: 5.270

2.  Mortality in Schizophrenia and Other Psychoses: Data from the South Korea National Health Insurance Cohort, 2002-2013.

Authors:  Woorim Kim; Suk Yong Jang; Sung Youn Chun; Tae Hoon Lee; Kyu Tae Han; Eun Cheol Park
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

3.  Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.

Authors:  Robert Howard; Elizabeth Cort; Rosie Bradley; Emma Harper; Linda Kelly; Peter Bentham; Craig Ritchie; Suzanne Reeves; Waleed Fawzi; Gill Livingston; Andrew Sommerlad; Sabu Oomman; Ejaz Nazir; Ramin Nilforooshan; Robert Barber; Chris Fox; Ajay Verma Macharouthu; Pranathi Ramachandra; Vivek Pattan; John Sykes; Val Curran; Cornelius Katona; Tom Dening; Martin Knapp; Richard Gray
Journal:  Lancet Psychiatry       Date:  2018-06-04       Impact factor: 27.083

Review 4.  Psychotic disorders in late life: a narrative review.

Authors:  Rajesh R Tampi; Juan Young; Rakin Hoq; Kyle Resnick; Deena J Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2019-10-16

Review 5.  Clinical Approaches to Late-Onset Psychosis.

Authors:  Kiwon Kim; Hong Jin Jeon; Woojae Myung; Seung Wan Suh; Su Jeong Seong; Jae Yeon Hwang; Je Il Ryu; Seon-Cheol Park
Journal:  J Pers Med       Date:  2022-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.